Deals of the day-Mergers and acquisitions

(Adds Volksbank Vorarlberg, Euronext; Updates China Communications Construction)

Nov 29 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday:

** Spain's BBVA said it had agreed to sell 80 percent of its real estate business to U.S. fund Cerberus for 4 billion euros ($5 billion), one of the largest such deals as investor enthusiasm for Spanish property returns.

** Euronext said it was buying 100 percent of the Irish Stock Exchange (ISE) for 137 million euros ($162.48 million) - a deal aimed at boosting the pan-European exchange's position in debt and fund listings.

** Austrian lender Volksbank Vorarlberg A said it expects to agree a sale of its Swiss unit Volksbank Schweiz by the end of the year, without elaborating on the potential buyer.

** China Communications Construction Co Ltd and Japan's Mitsubishi Group and Sumitomo Corp are vying for a stake in a railroad owned by Brazil's Rumo SA, a person familiar with the matter told Reuters.

** Daimler AG has turned down an offer from China's Geely to take a stake of up to 5 percent via a discounted share placement, as the German automaker has long been reluctant to see existing shareholdings diluted, sources with knowledge of the talks said.

** The biggest shareholders in Etalon sold 9.5 percent of company shares for $95.2 million, the Russian housebuilder said, reducing their holdings for the second time this year.

** Vietnam will kick off next month the sale of a majority stake in the Sabeco, the country's biggest brewer and the maker of Bia Saigon and 333 beers, in an ambitious deal the government hopes will rake in at least $5 billion.

** French investment company Eurazeo has agreed to buy a 30 percent stake in Rhone, a private equity firm set up by former Goldman Sachs and Lazard bankers, in a deal which Eurazeo said would boost its earnings.

** Kaisa Group Holdings Ltd said it planned to spend $322 million buying 19 percent of blood products firm Zhenxing Biopharmaceutical & Chemical Co Ltd, as the once-troubled Chinese property developer continues to diversify. (Compiled by Sanjana Shivdas and Akankshita Mukhopadhyay in Bengaluru)